THURSDAY, 5 MAY
Carotid revascularization: stenting vs surgery
PRO
C. Cernetti (Castelfranco Veneto)
CONS
F. Grego (Padua)
Symptomatic carotid stenosis: are the results of the old trials still valid?
E. Cagliari (Mestre)
CREST 2: a randomized trial in asymptomatic carotid stenosis
M. Giordan (Rovigo)
Medical management rocks for carotid disease
G. Pasquetto (Este)
Intracranial aneurysm treatment: endovascular vs surgery
PRO
S. Mangiafico (Florence)
CONS
F. Guida (Mestre)
New devices for endovascular embolization of cerebral aneurysms
L. Valvassori (Milan)
AV malformation and fistulas: surgery and embolization
F. Causin (Padua)
The real-world treatment of hemorrhages associated with NOAC
V. Pengo (Padua)
What I learned from a complex carotid stenting I will never forget
S. Saccà (Mirano)
What I learned from an unruptured complex cerebral aneurysm treatment that I will never forget
Della Puppa (Padua)
What I learned from a ruptured complex cerebral aneurysm treatment that I will never forget
I. Linfante (Miami)
Revascularization strategies in patients with combined carotid and coronary artery disease
F. Castriota (Cotignola)
Plenary lecture
Carotid artery percutaneous treatment: back to the future
A. Cremonesi (Cotignola)
FRIDAY, 6 MAY
Intracranial revascularization in Acute Stroke: Data and Trials
S. Mangiafico (Florence)
Acute Stroke Intervention: Devices, Tips and Tricks
L. Valvassori (Milan)
Patient selection for endovascular treatment
F. Ribichini (Verona)
Patient pathways in acute carotid syndromes after the new trials results
D. Toni (Rome)
Endovascular therapy reduces disability from stroke: studies confirm
F. Causin (Padua)
Plenary lecture
Acute stroke intervention: clinical trials and beyond
I. Linfante (Miami)
Left atrial appendage closure can be considered a real alternative to anticoagulation?
S. Berti (Massa)
Combined catheter ablation and left atrial appendage closure as a hybrid procedure for the treatment of atrial fibrillation
G. Molon (Negrar)
How LAAC and NOAC have changed our life in Stroke prevention in non valvular AFib patients
F. Di Pede (Portogruaro)
New surgical approaches for LAAC closure
D. Mangino (Mestre)
Procedural outcome of patients with estimated low, intermediate or high stroke risk undergoing percutaneous LAAC using Amplatzer systems
A.B. Ramondo (Vicenza)
Transcatheter aortic valve implantation
F. Caprioglio (Mestre)
Sutureless aortic valve replacement
G. Zoffoli (Mestre)
Aneurysm coiling and flow diverters
I. Linfante (Miami)
Neurologic complications after transradial or transfemoral approach for diagnostic and interventional cardiac catheterization
P. Buja (Padua)
Percutaneous PFO closure in prevention of stroke or transient ischemic attack: is it time to consider it? Interventional cardiologist point of view
G. Rigatelli (Rovigo)
Percutaneous PFO in prevention of stroke or transient ischemic attack: is it time to consider it? Neurologist point of view
A. Critelli (Mestre)
New oral anticoagulant therapy for stroke prevention in patients with atrial fi brillation undergoing ablation
G. Buja (Padua)
Surgical minimally invasive pulmonary vein isolation for atrial fi brillation: when and to whom?
A. Venturini (Mestre)
Impact of transesophageal echocardiography on management in patients with suspected cardio embolic stroke
F. Rigo (Mestre)
What I learned from a complex case of endovascular stroke treatment
I. Linfante (Miami)
What I learned from a complex transapical aortic valve implantation
C. Zanchettin (Mestre)
What I learned from a complex transcatheter aortic valve implantation
M. Barbierato (Mestre)
What I learned from a complex percutaneous LAAC
F. Ronco (Venice)
SATURDAY, 7 MAY
Effectiveness of regionalized systems for stroke and myocardial infarction: 6 years of experience
G. Pasquetto (Este)
Effectiveness of regionalized systems for stroke and myocardial infarction: the new Stroke age
D. Toni (Rome)
Interventional cardiologist in acute stroke…? The ESC Task Force on stroke Iniziative
F. Ribichini (Verona)
The optimal DAPT duration in the new generation stent era
G. Pasquetto (Este)
Different DAPT for different risk profi le patients: tailoring the best therapy
E. Franceschini (Belluno)
DAPT and NOAC in patient undergoing PCI: a mission impossible?
L. Roncon (Rovigo)
Pre-treatment with P2Y12 inhibitors in ACS patients: who, when, why, and which agent
G. Zuin (Mestre)
Haemorrhagic risk in the P2Y12 receptor inhibitor era
L. Pedon (Cittadella)